2026-01-12 - Analysis Report
**Financial Report for Lam Research Corporation (LRCX)**

**Company Overview**
Lam Research Corporation is a global leader in the development and manufacturing of innovative semiconductor equipment and materials.

**Return Rate Comparison**
- Cumulative return of review stock (LRCX): 306.49%
- Cumulative return of comparison stock (S&P 500, VOO): 94.03%
- Divergence (max: 212.50, min: -14.70, current: 212.50, relative divergence: 100.00%)

**Market Analysis**

| Year          | CAGR | MDD | Alpha | Beta | Cap(B) |
|---------------|------|-----|-------|------|--------|
| 2016-2018      | 1.0% | 34.2% | -2.0% | 1.6 | 17.2B  |
| 2017-2019      | 38.0% | 34.2% | 21.0% | 1.7 | 36.9B  |
| 2018-2020      | 57.0% | 34.2% | 36.0% | 1.5 | 59.5B  |
| 2019-2021      | 105.0% | 24.5% | 62.0% | 1.6 | 90.7B  |
| 2020-2022      | -11.0% | 49.0% | -9.0% | 1.6 | 53.0B  |
| 2021-2023      | -14.0% | 49.0% | -15.0% | 1.8 | 98.8B  |
| 2022-2024      | -47.0% | 42.4% | -66.0% | 1.9 | 91.1B  |
| 2023-2025      | 150.0% | 43.7% | 88.0% | 2.0 | 215.9B |

**Recent Stock Price Fluctuations**
- Close: $218.36
- Last-market: {'price': 218.36, 'previousClose': 200.96, 'change': 8.66}
- 5-day SMA: $204.82
- 20-day SMA: $179.23
- 60-day SMA: $162.45

**RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**
- Market Risk Indicator (MRI): 0.70 (High Investment Recommended)
- RSI: 83.69
- PPO: 1.88
- Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: 0.00 (flat)
- 7-day Rank change: -1 (-) rank down
- 7-day Dynamic Expected Return change: 0.10 (+) improving
- Expected Return (%): 11.10%

**Recent News & Significant Events**

*   [2025-12-19] Why Is Lam Research (LRCX) Stock Soaring Today - Yahoo Finance
*   [2026-01-09] Why Is Lam Research (LRCX) Stock Soaring Today - Finviz
*   [2026-01-11] Bayforest Capital Ltd Makes New Investment in Lam Research Corporation $LRCX - MarketBeat
*   [2026-01-09] $LRCX stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
*   [2026-01-06] Why Lam Research (LRCX) Stock Is Trading Up Today - The Globe and Mail
*   [2025-12-22] Is Lam Research (LRCX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Nasdaq

**Analyst Opinions**
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.77 (~Buy)
  - Opinions: 30
  - Target Price (avg/high/low): 177.80 / 265.00 / 115.00

**Recent Earnings Analysis**

| Date        | EPS | Revenue |
|-------------|-----|---------|
| 2025-10-24  | 1.24 | $5.32B  |
| 2025-04-25  | 1.04 | $4.72B  |
| 2025-01-31  | 0.93 | $4.38B  |
| 2024-10-28  | 0.86 | $4.17B  |
| Duplicate row | 0.86 | $4.17B  |

**Revenue and Profitability**

| Quarter       | Revenue | Profit Margin |
|---------------|---------|---------------|
| 2025-09-30    | $5.32B  | 50.43%        |
| 2025-06-30    | $5.17B  | 50.08%        |
| 2025-03-31    | $4.72B  | 49.02%        |
| 2024-12-31    | $4.38B  | 47.37%        |
| 2024-09-30    | $4.17B  | 48.05%        |

**Capital and Profitability**

| Quarter       | Equity | ROE |
|---------------|---------|-----|
| 2025-09-30    | $10.19B | 15.39%|
| 2025-06-30    | $9.86B  | 17.44%|
| 2025-03-31    | $9.51B  | 13.99%|
| 2024-12-31    | $8.81B  | 13.52%|
| 2024-09-30    | $8.47B  | 13.18%|

**Comprehensive Analysis (Summary of previous items)**

Based on the provided data, Lam Research Corporation (LRCX) has shown significant growth in cumulative returns, beating the S&P 500 (VOO) by a substantial margin. The company's market analysis shows a mix of positive and negative trends over the years, with a CAGR ranging from 1.0% to 150.0%. The recent stock price fluctuations indicate a moderate upward trend, with short-term moving averages still below the current price.

The RSI and PPO index indicators suggest overbought conditions, with a high risk level indicated by the Market Risk Indicator (MRI). However, the hybrid signal remains a buy, and the expected return is positive at 11.10%. Recent news and significant events highlight a strong stock price performance, with analyst opinions mostly positive, recommending a buy with a target price range of $177.80 to $265.00.

The recent earnings analysis shows a mixed picture, with earnings per share (EPS) and revenue growth varying over the quarters. Profit margins have been relatively consistent, ranging from 47.37% to 50.43%. The company's capital and profitability have also shown a mixed trend, with equity growth and return on equity (ROE) varying over the quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.